MedTrace Logo

Objective, Passive Assessment of LRRK2 Carriers

NCT05287620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-06-28

No results posted yet for this study

Summary

The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless sensor and analyzing the radio signals that bounce off patients' bodies, while patients go about their normal life without needing to wear sensors, answer questionnaires, or actively perform any tests.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Emerald device

The Emerald device is a wireless sensor that can track the motion, breathing, and sleep of participants without touching or requiring any interaction with the participants, allowing them to go about their normal lives. The Emerald device operates by transmitting and receiving low power radio signals that reflect off of the participant and return back to the device. The power of these signals is 1,000 times lower than what a typical Wi-Fi device transmits. The ability of the device to monitor gait, breathing, sleep, and other metrics has been validated and documented. Studies of the Emerald device in individuals with Parkinson's disease, Alzheimer's disease, and rare diseases have demonstrated the feasibility of monitoring at home and the ability to characterize gait, breathing, and sleep in these populations specifically. In this study, the Emerald device will be used to characterize the mobility, breathing and sleep of the participant.

Sponsors & Collaborators

  • Emerald Innovations

    collaborator UNKNOWN

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • University of Rochester

    lead OTHER

Principal Investigators

  • Ray Dorsey, MD · University of Rochester

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-27
Primary Completion
2024-05-07
Completion
2024-05-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05287620 on ClinicalTrials.gov